Immune modulation by virus-encoded secreted chemokine binding proteins

Virus Research

Volumn 209, Issue , 2015, Pages 67-75

  Heidarieh, Haleh ^a   Hernáez, Bruno ^a   Alcamí, Antonio ^a  

^a CSIC   (Spain)

Author keywords

Chemokine binding proteins; Chemokines; Glycosaminoglycans; Herpesviruses; Immune evasion; Poxviruses

Indexed keywords

BINDING PROTEIN; CHEMOKINE; CHEMOKINE BINDING PROTEIN; UNCLASSIFIED DRUG; DNA VIRUS; PROTEIN BINDING;

ADAPTIVE IMMUNITY; ARTICLE; BINDING AFFINITY; CELL MIGRATION; DNA VIRUS; HERPESVIRIDAE; IMMUNE EVASION; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INNATE IMMUNITY; NONHUMAN; POXVIRIDAE; PRIORITY JOURNAL; VIRUS PATHOGENESIS; ANIMAL; DISEASE MODEL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; CHEMOKINES; DISEASE MODELS, ANIMAL; DNA VIRUSES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNE TOLERANCE; PROTEIN BINDING;

EID: 84959542315     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2015.02.028     Document Type: Article

References (98)

1. Alcami A. Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 2003, 3(1):36-50.
2. Alcami A., Koszinowski U.H. Viral mechanisms of immune evasion. Immunol. Today 2000, 21(9):447-455.
3. Alcami A., Symons J.A., Collins P.D., Williams T.J., Smith G.L. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J. Immunol. 1998, 160(2):624-633.
4. Alejo A., Ruiz-Arguello M.B., Ho Y., Smith V.P., Saraiva M., Alcami A. A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(15):5995-6000.
5. Alexander J.M., Nelson C.A., van Berkel V., Lau E.K., Studts J.M., Brett T.J., Speck S.H., Handel T.M., Virgin H.W., Fremont D.H. Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell 2002, 111(3):343-356.
6. Alexander-Brett J.M., Fremont D.H. Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor. J. Exp. Med. 2007, 204(13):3157-3172.
7. Antonets D.V., Nepomnyashchikh T.S., Shchelkunov S.N. SECRET domain of variola virus CrmB protein can be a member of poxviral type II chemokine-binding proteins family. BMC Res. Notes 2010, 3:271.
8. Arnold P.L., Fremont D.H. Structural determinants of chemokine binding by an Ectromelia virus-encoded decoy receptor. J. Virol. 2006, 80(15):7439-7449.
9. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998, 392(6676):565-568.
10. Bahar M.W., Kenyon J.C., Putz M.M., Abrescia N.G., Pease J.E., Wise E.L., Stuart D.I., Smith G.L., Grimes J.M. Structure and function of A41, a vaccinia virus chemokine binding protein. PLoS Pathog. 2008, 4(1):e5.
11. Balan P., Davis-Poynter N., Bell S., Atkinson H., Browne H., Minson T. An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus type 1 lacking glycoproteins gG, gE, gI or the putative gJ. J. Gen. Virol. 1994, 75(Pt 6):1245-1258.
12. Bartee M.Y., Chen H., Dai E., Liu L.Y., Davids J.A., Lucas A. Defining the anti-inflammatory activity of a potent myxomaviral chemokine modulating protein, M-T7, through site directed mutagenesis. Cytokine 2013, 65(1):79-87.
13. Beck C.G., Studer C., Zuber J.F., Demange B.J., Manning U., Urfer R. The viral CC chemokine-binding protein vCCI inhibits monocyte chemoattractant protein-1 activity by masking its CCR2B-binding site. J. Biol. Chem. 2001, 276(46):43270-43276.
14. Bedard E.L., Kim P., Jiang J., Parry N., Liu L., Wang H., Garcia B., Li X., McFadden G., Lucas A., Zhong R. Chemokine-binding viral protein M-T7 prevents chronic rejection in rat renal allografts. Transplantation 2003, 76(1):249-252.
15. Biron C.A. Interferons alpha and beta as immune regulators - a new look. Immunity 2001, 14(6):661-664.
16. Blanpain C., Doranz B.J., Bondue A., Govaerts C., De Leener A., Vassart G., Doms R.W., Proudfoot A., Parmentier M. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle. J. Biol. Chem. 2003, 278(7):5179-5187.
17. Boomker J.M., Luttikhuizen D.T., Veninga H., de Leij L.F., The T.H., de Haan A., van Luyn M.J., Harmsen M.C. The modulation of angiogenesis in the foreign body response by the poxviral protein M-T7. Biomaterials 2005, 26(23):4874-4881.
18. Bridgeman A., Stevenson P.G., Simas J.P., Efstathiou S. A secreted chemokine binding protein encoded by murine gammaherpesvirus-68 is necessary for the establishment of a normal latent load. J. Exp. Med. 2001, 194(3):301-312.
19. Bryant N.A., Davis-Poynter N., Vanderplasschen A., Alcami A. Glycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins. EMBO J. 2003, 22(4):833-846.
20. Buatois V., Fagete S., Magistrelli G., Chatel L., Fischer N., Kosco-Vilbois M.H., Ferlin W.G. Pan-CC chemokine neutralization restricts splenocyte egress and reduces inflammation in a model of arthritis. J. Immunol. 2010, 185(4):2544-2554.
21. Burns J.M., Dairaghi D.J., Deitz M., Tsang M., Schall T.J. Comprehensive mapping of poxvirus vCCI chemokine-binding protein. Expanded range of ligand interactions and unusual dissociation kinetics. J. Biol. Chem. 2002, 277(4):2785-2789.
22. Bursill C.A., McNeill E., Wang L., Hibbitt O.C., Wade-Martins R., Paterson D.J., Greaves D.R., Channon K.M. Lentiviral gene transfer to reduce atherosclerosis progression by long-term CC-chemokine inhibition. Gene Ther. 2009, 16(1):93-102.
23. Carfi A., Smith C.A., Smolak P.J., McGrew J., Wiley D.C. Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus. Proc. Natl. Acad. Sci. U.S.A. 1999, 96(22):12379-12383.
24. Clark R.H., Kenyon J.C., Bartlett N.W., Tscharke D.C., Smith G.L. Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy. J. Gen. Virol. 2006, 87(Pt 1):29-38.
25. Costes B., Ruiz-Arguello M.B., Bryant N.A., Alcami A., Vanderplasschen A. Both soluble and membrane-anchored forms of felid herpesvirus 1 glycoprotein G function as a broad-spectrum chemokine-binding protein. J. Gen. Virol. 2005, 86(Pt 12):3209-3214.
26. Costes B., Thirion M., Dewals B., Mast J., Ackermann M., Markine-Goriaynoff N., Gillet L., Vanderplasschen A. Felid herpesvirus 1 glycoprotein G is a structural protein that mediates the binding of chemokines on the viral envelope. Microbes Infect. 2006, 8(11):2657-2667.
27. Counago R.M., Fleming S.B., Mercer A.A., Krause K.L. Crystallization and preliminary X-ray analysis of the chemokine-binding protein from orf virus (Poxviridae). Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2010, 66(Pt 7):819-823.
28. Dealwis C., Fernandez E.J., Thompson D.A., Simon R.J., Siani M.A., Lolis E. Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1alpha, a potent ligand for the HIV-1 "fusin" coreceptor. Proc. Natl. Acad. Sci. U.S.A. 1998, 95(12):6941-6946.
29. Deruaz M., Frauenschuh A., Alessandri A.L., Dias J.M., Coelho F.M., Russo R.C., Ferreira B.R., Graham G.J., Shaw J.P., Wells T.N., Teixeira M.M., Power C.A., Proudfoot A.E. Ticks produce highly selective chemokine binding proteins with antiinflammatory activity. J. Exp. Med. 2008, 205(9):2019-2031.
30. Devlin J.M., Browning G.F., Hartley C.A., Gilkerson J.R. Glycoprotein G deficient infectious laryngotracheitis virus is a candidate attenuated vaccine. Vaccine 2007, 25(18):3561-3566.
31. Devlin J.M., Viejo-Borbolla A., Browning G.F., Noormohammadi A.H., Gilkerson J.R., Alcami A., Hartley C.A. Evaluation of immunological responses to a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus. Vaccine 2010, 28(5):1325-1332.
32. Dias J.M., Losberger C., Deruaz M., Power C.A., Proudfoot A.E., Shaw J.P. Structural basis of chemokine sequestration by a tick chemokine binding protein: the crystal structure of the complex between Evasin-1 and CCL3. PLoS ONE 2009, 4(12):e8514.
33. Dyer D.P., Thomson J.M., Hermant A., Jowitt T.A., Handel T.M., Proudfoot A.E., Day A.J., Milner C.M. TSG-6 inhibits neutrophil migration via direct interaction with the chemokine CXCL8. J. Immunol. 2014, 192(5):2177-2185.
34. Fernandez E.J., Lolis E. Structure, function, and inhibition of chemokines. Annu. Rev. Pharmacol. Toxicol. 2002, 42:469-499.
35. Finlay B.B., McFadden G. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 2006, 124(4):767-782.
36. Frauenschuh A., Power C.A., Deruaz M., Ferreira B.R., Silva J.S., Teixeira M.M., Dias J.M., Martin T., Wells T.N., Proudfoot A.E. Molecular cloning and characterization of a highly selective chemokine-binding protein from the tick Rhipicephalus sanguineus. J. Biol. Chem. 2007, 282(37):27250-27258.
37. Garcia-Arriaza J., Najera J.L., Gomez C.E., Sorzano C.O., Esteban M. Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions. PLoS ONE 2010, 5(8):e12395.
38. Gomi Y., Sunamachi H., Mori Y., Nagaike K., Takahashi M., Yamanishi K. Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J. Virol. 2002, 76(22):11447-11459.
39. Graham G.J., McKimmie C.S. Chemokine scavenging by D6: a movable feast?. Trends Immunol. 2006, 27(8):381-386.
40. Graham K.A., Lalani A.S., Macen J.L., Ness T.L., Barry M., Liu L.Y., Lucas A., Clark-Lewis I., Moyer R.W., McFadden G. The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 1997, 229(1):12-24.
41. Guidotti L.G., Chisari F.V. Cytokine-mediated control of viral infections. Virology 2000, 273(2):221-227.
42. Haig D.M., Fleming S. Immunomodulation by virulence proteins of the parapoxvirus orf virus. Vet. Immunol. Immunopathol. 1999, 72(1-2):81-86.
43. Handel T.M., Johnson Z., Crown S.E., Lau E.K., Proudfoot A.E. Regulation of protein function by glycosaminoglycans - as exemplified by chemokines. Annu. Rev. Biochem. 2005, 74:385-410.
44. Hu F.Q., Smith C.A., Pickup D.J. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology 1994, 204(1):343-356.
45. Hughes D.J., Kipar A., Leeming G.H., Bennett E., Howarth D., Cummerson J.A., Papoula-Pereira R., Flanagan B.F., Sample J.T., Stewart J.P. Chemokine binding protein M3 of murine gammaherpesvirus 68 modulates the host response to infection in a natural host. PLoS Pathog. 2011, 7(3):e1001321.
46. Johnson Z., Proudfoot A.E., Handel T.M. Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention. Cytokine Growth Factor Rev. 2005, 16(6):625-636.
47. Kimman T.G., Pol J.M., de Wind N., Oei-Lie N., Berns A.J., Gielkens A.L. Role of different genes in the virulence and pathogenesis of Aujeszky's disease virus. Vet. Microbiol. 1992, 33(1-4):45-52.
48. Kuo N.W., Gao Y.G., Schill M.S., Isern N., Dupureur C.M., Liwang P.J. Structural insights into the interaction between a potent anti-inflammatory protein, viral CC chemokine inhibitor (vCCI), and the human CC chemokine, Eotaxin-1. J. Biol. Chem. 2014, 289(10):6592-6603.
49. Lalani A.S., Graham K., Mossman K., Rajarathnam K., Clark-Lewis I., Kelvin D., McFadden G. The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. J. Virol. 1997, 71(6):4356-4363.
50. Lalani A.S., Masters J., Graham K., Liu L., Lucas A., McFadden G. Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis. Virology 1999, 256(2):233-245.
51. Lalani A.S., Ness T.L., Singh R., Harrison J.K., Seet B.T., Kelvin D.J., McFadden G., Moyer R.W. Functional comparisons among members of the poxvirus T1/35kDa family of soluble CC-chemokine inhibitor glycoproteins. Virology 1998, 250(1):173-184.
52. Lateef Z., Baird M.A., Wise L.M., Mercer A.A., Fleming S.B. Orf virus-encoded chemokine-binding protein is a potent inhibitor of inflammatory monocyte recruitment in a mouse skin model. J. Gen. Virol. 2009, 90(Pt 6):1477-1482.
53. Lateef Z., Baird M.A., Wise L.M., Young S., Mercer A.A., Fleming S.B. The chemokine-binding protein encoded by the poxvirus orf virus inhibits recruitment of dendritic cells to sites of skin inflammation and migration to peripheral lymph nodes. Cell. Microbiol. 2010, 12(5):665-676.
54. Liu L., Dai E., Miller L., Seet B., Lalani A., Macauley C., Li X., Virgin H.W., Bunce C., Turner P., Moyer R., McFadden G., Lucas A. Viral chemokine-binding proteins inhibit inflammatory responses and aortic allograft transplant vasculopathy in rat models. Transplantation 2004, 77(11):1652-1660.
55. Loh J., Zhao G., Nelson C.A., Coder P., Droit L., Handley S.A., Johnson L.S., Vachharajani P., Guzman H., Tesh R.B., Wang D., Fremont D.H., Virgin H.W. Identification and sequencing of a novel rodent gammaherpesvirus that establishes acute and latent infection in laboratory mice. J. Virol. 2011, 85(6):2642-2656.
56. Loparev V.N., Parsons J.M., Knight J.C., Panus J.F., Ray C.A., Buller R.M., Pickup D.J., Esposito J.J. A third distinct tumor necrosis factor receptor of orthopoxviruses. Proc. Natl. Acad. Sci. U.S.A. 1998, 95(7):3786-3791.
57. Lubman O.Y., Cella M., Wang X., Monte K., Lenschow D.J., Huang Y.H., Fremont D.H. Rodent herpesvirus Peru encodes a secreted chemokine decoy receptor. J. Virol. 2014, 88(1):538-546.
58. Mantovani A., Bonecchi R., Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat. Rev. Immunol. 2006, 6(12):907-918.
59. Martinez-Pomares L., Thompson J.P., Moyer R.W. Mapping and investigation of the role in pathogenesis of the major unique secreted 35-kDa protein of rabbitpox virus. Virology 1995, 206(1):591-600.
60. Meignier B., Longnecker R., Mavromara-Nazos P., Sears A.E., Roizman B. Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1. Virology 1988, 162(1):251-254.
61. Mossman K., Nation P., Macen J., Garbutt M., Lucas A., McFadden G. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology 1996, 215(1):17-30.
62. Mossman K., Upton C., McFadden G. The myxoma virus-soluble interferon-gamma receptor homolog, M-T7, inhibits interferon-gamma in a species-specific manner. J. Biol. Chem. 1995, 270(7):3031-3038.
63. Ng A., Tscharke D.C., Reading P.C., Smith G.L. The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence. J. Gen. Virol. 2001, 82(Pt 9):2095-2105.
64. Palumbo G.J., Buller R.M., Glasgow W.C. Multigenic evasion of inflammation by poxviruses. J. Virol. 1994, 68(3):1737-1749.
65. Parry C.M., Simas J.P., Smith V.P., Stewart C.A., Minson A.C., Efstathiou S., Alcami A. A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J. Exp. Med. 2000, 191(3):573-578.
66. Price N., Tscharke D.C., Hollinshead M., Smith G.L. Vaccinia virus gene B7R encodes an 18-kDa protein that is resident in the endoplasmic reticulum and affects virus virulence. Virology 2000, 267(1):65-79.
67. Proudfoot A.E. Chemokine receptors: multifaceted therapeutic targets. Nat. Rev. Immunol. 2002, 2(2):106-115.
68. Proudfoot A.E. The biological relevance of chemokine-proteoglycan interactions. Biochem. Soc. Trans. 2006, 34(Pt 3):422-426.
69. Reading P.C., Symons J.A., Smith G.L. A soluble chemokine-binding protein from vaccinia virus reduces virus virulence and the inflammatory response to infection. J. Immunol. 2003, 170(3):1435-1442.
70. Ruiz-Arguello M.B., Smith V.P., Campanella G.S., Baleux F., Arenzana-Seisdedos F., Luster A.D., Alcami A. An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain. J. Virol. 2008, 82(2):917-926.
71. Saraiva M., Alcami A. CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses. J. Virol. 2001, 75(1):226-233.
72. Seet B.T., Johnston J.B., Brunetti C.R., Barrett J.W., Everett H., Cameron C., Sypula J., Nazarian S.H., Lucas A., McFadden G. Poxviruses and immune evasion. Annu. Rev. Immunol. 2003, 21:377-423.
73. Seet B.T., McCaughan C.A., Handel T.M., Mercer A., Brunetti C., McFadden G., Fleming S.B. Analysis of an orf virus chemokine-binding protein: Shifting ligand specificities among a family of poxvirus viroceptors. Proc. Natl. Acad. Sci. U.S.A. 2003, 100(25):15137-15142.
74. Seet B.T., Singh R., Paavola C., Lau E.K., Handel T.M., McFadden G. Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor. Proc. Natl. Acad. Sci. U.S.A. 2001, 98(16):9008-9013.
75. Smith C.A., Hu F.Q., Smith T.D., Richards C.L., Smolak P., Goodwin R.G., Pickup D.J. Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha. Virology 1996, 223(1):132-147.
76. Smith C.A., Smith T.D., Smolak P.J., Friend D., Hagen H., Gerhart M., Park L., Pickup D.J., Torrance D., Mohler K., Schooley K., Goodwin R.G. Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors. Virology 1997, 236(2):316-327.
77. Smith G.L., McFadden G. Smallpox: anything to declare?. Nat. Rev. Immunol. 2002, 2(7):521-527.
78. Smith P., Fallon R.E., Mangan N.E., Walsh C.M., Saraiva M., Sayers J.R., McKenzie A.N., Alcami A., Fallon P.G. Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity. J. Exp. Med. 2005, 202(10):1319-1325.
79. Thomsen D.R., Marchioli C.C., Yancey R.J., Post L.E. Replication and virulence of pseudorabies virus mutants lacking glycoprotein gX. J. Virol. 1987, 61(1):229-232.
80. Upton C., Macen J.L., Schreiber M., McFadden G. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 1991, 184(1):370-382.
81. Upton C., Mossman K., McFadden G. Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science 1992, 258(5086):1369-1372.
82. van Berkel V., Barrett J., Tiffany H.L., Fremont D.H., Murphy P.M., McFadden G., Speck S.H., Virgin H.I. Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J. Virol. 2000, 74(15):6741-6747.
83. van Berkel V., Levine B., Kapadia S.B., Goldman J.E., Speck S.H., Virgin H.W. Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis. J. Clin. Invest. 2002, 109(7):905-914.
84. Van de Walle G.R., Kaufer B.B., Chbab N., Osterrieder N. Analysis of the herpesvirus chemokine-binding glycoprotein G residues essential for chemokine binding and biological activity. J. Biol. Chem. 2009, 284(9):5968-5976.
85. Van de Walle G.R., May M.L., Sukhumavasi W., von Einem J., Osterrieder N. Herpesvirus chemokine-binding glycoprotein G (gG) efficiently inhibits neutrophil chemotaxis in vitro and in vivo. J. Immunol. 2007, 179(6):4161-4169.
86. Viejo-Borbolla A., Martin A.P., Muniz L.R., Shang L., Marchesi F., Thirunarayanan N., Harpaz N., Garcia R.A., Apostolaki M., Furtado G.C., Mayer L., Kollias G., Alcami A., Lira S.A. Attenuation of TNF-driven murine ileitis by intestinal expression of the viral immunomodulator CrmD. Mucosal Immunol. 2010, 3(6):633-644.
87. Viejo-Borbolla A., Martinez-Martin N., Nel H.J., Rueda P., Martin R., Blanco S., Arenzana-Seisdedos F., Thelen M., Fallon P.G., Alcami A. Enhancement of chemokine function as an immunomodulatory strategy employed by human herpesviruses. PLoS Pathog. 2012, 8(2):e1002497.
88. Viejo-Borbolla A., Munoz A., Tabares E., Alcami A. Glycoprotein G from pseudorabies virus binds to chemokines with high affinity and inhibits their function. J. Gen. Virol. 2010, 91(Pt 1):23-31.
89. von Einem J., Smith P.M., Van de Walle G.R., O'Callaghan D.J., Osterrieder N. In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG). Virology 2007, 362(1):151-162.
90. Wang D., Bresnahan W., Shenk T. Human cytomegalovirus encodes a highly specific RANTES decoy receptor. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(47):16642-16647.
91. Webb L.M., Clark-Lewis I., Alcami A. The gammaherpesvirus chemokine binding protein binds to the N terminus of CXCL8. J. Virol. 2003, 77(15):8588-8592.
92. Webb L.M., Smith V.P., Alcami A. The gammaherpesvirus chemokine binding protein can inhibit the interaction of chemokines with glycosaminoglycans. FASEB J. 2004, 18(3):571-573.
93. Weber P.C., Levine M., Glorioso J.C. Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis. Science 1987, 236(4801):576-579.
94. White G.E., McNeill E., Christou I., Channon K.M., Greaves D.R. Site-directed mutagenesis of the CC chemokine binding protein 35K-Fc reveals residues essential for activity and mutations that increase the potency of CC chemokine blockade. Mol. Pharmacol. 2011, 80(2):328-336.
95. Xue X., Lu Q., Wei H., Wang D., Chen D., He G., Huang L., Wang H., Wang X. Structural basis of chemokine sequestration by CrmD, a poxvirus-encoded tumor necrosis factor receptor. PLoS Pathog. 2011, 7(7):e1002162.
96. Zhang L., Derider M., McCornack M.A., Jao S.C., Isern N., Ness T., Moyer R., LiWang P.J. Solution structure of the complex between poxvirus-encoded CC chemokine inhibitor vCCI and human MIP-1beta. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(38):13985-13990.
97. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12(2):121-127.
98. Zlotnik A., Yoshie O., Nomiyama H. The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol. 2006, 7(12):243.